ribavirin has been researched along with Muscle Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abravanel, F; Belliere, J; Cintas, P; Cointault, O; Faguer, S; Izopet, J; Kamar, N; Lavayssière, L; Lhomme, S; Martinez, S; Nogier, MB | 1 |
| Delforge, ML; Deviere, J; Golstein, PE; Marcellin, P | 1 |
| Kizawa, H; Kondoh, R; Nagane, Y; Terayama, Y; Utsugisawa, K | 1 |
3 other study(ies) available for ribavirin and Muscle Disorders
| Article | Year |
|---|---|
Transfusion-acquired hepatitis E infection misdiagnosed as severe critical illness polyneuromyopathy in a heart transplant patient.
Topics: Antiviral Agents; Blood Transfusion; Critical Illness; Diagnostic Errors; Fatal Outcome; Heart Transplantation; Hepatitis E; Hepatitis E virus; Humans; Male; Middle Aged; Multiple Organ Failure; Muscular Diseases; Polyneuropathies; Polyradiculoneuropathy; Postoperative Period; Ribavirin; RNA, Viral | 2017 |
Reversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis C.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Bilirubin; Creatine Kinase; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Interferon alpha-2; Interferon-alpha; Male; Muscular Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral | 2004 |
[Hypothyroid myopathy caused by interferon-alpha therapy for chronic hepatitis C].
Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Hypothyroidism; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Muscular Diseases; Recombinant Proteins; Ribavirin | 2005 |